Prostate cancer sufferers in England and Wales are being denied a ‘wonder pill’ that is widely available in Scotland.
Abiraterone produced such stunning results in trials that it was hailed as the biggest breakthrough in the field for 60 years.
It shrinks advanced tumours that have spread throughout the body. The NHS in England and Wales limits its use to men who have already had chemotherapy. But Scotland has just made it available pre-chemo – when it might be even more effective.
In a second example of ‘health apartheid’, the Scottish drugs rationing body has also given the green light to prostate cancer treatment using radium 223.
The National Institute for Health and Clinical Excellence is expected to approve it for NHS use in England and Wales in January. But only for post-chemotherapy use.
Hugh Gunn, from the cancer charity Tackle, said hundreds of men could lose out. He said: ‘It is very important these drugs are made available.
‘These drugs work for longer and are far more effective if they are given before chemotherapy.’
Professor Paul Workman, of the Institute for Cancer Research in London, said patients south of the border were being ‘denied’ abiraterone, adding: ‘What’s excellent news for Scotland will only reinforce the frustration for patients in England and Wales.’
Abiraterone, which was discovered by scientists at the Institute for Cancer Research at London’s Royal Marsden Hospital, costs around £36,000 a year.
Men who take it in pill form four times a day live an average of four months longer.
Owen Sharp, of the Prostate Cancer Charity, said: ‘Four months may not appear to be very long, but those months could mean a man lives to see the birth of a grandchild or even just give him the chance to do more of the things we all take for granted – whilst still enjoying a good quality of life with much less pain and few side-effects.’
My dad was put on Abiraterone and it apparently extended his life for about 2-3 years. They thought it would only work for about 11 months. He has been very lucky. The treatment was withdrawn however immediately when the oncologists realised that the cancer was no longer suppressed by it. We are in the South of England not Scotland.
Sad to say that now that he is 80 it seems the NHS have lost all interest and have given up on him.
Prostate cancer sufferers are denied 'wonder pill' that's widely available to Scotshttps://www.carenity.co.uk/forum/other-discussions/your-opinion-on-cancer-treatments/prostate-cancer-sufferers-are-denied-wonder-pi-5922015-11-10 15:32:11
Gilda
Community managerGood advisor
Gilda
Community manager
Last activity on 03/02/2023 at 15:26
Joined in 2015
710 comments posted | 20 in the Treatments for cancer group
Rewards
Good Advisor
Contributor
Messenger
Committed
Explorer
Evaluator
Prostate cancer sufferers in England and Wales are being denied a ‘wonder pill’ that is widely available in Scotland.
Abiraterone produced such stunning results in trials that it was hailed as the biggest breakthrough in the field for 60 years.
It shrinks advanced tumours that have spread throughout the body. The NHS in England and Wales limits its use to men who have already had chemotherapy. But Scotland has just made it available pre-chemo – when it might be even more effective.
In a second example of ‘health apartheid’, the Scottish drugs rationing body has also given the green light to prostate cancer treatment using radium 223.
The National Institute for Health and Clinical Excellence is expected to approve it for NHS use in England and Wales in January. But only for post-chemotherapy use.
Hugh Gunn, from the cancer charity Tackle, said hundreds of men could lose out. He said: ‘It is very important these drugs are made available.
‘These drugs work for longer and are far more effective if they are given before chemotherapy.’
Professor Paul Workman, of the Institute for Cancer Research in London, said patients south of the border were being ‘denied’ abiraterone, adding: ‘What’s excellent news for Scotland will only reinforce the frustration for patients in England and Wales.’
Abiraterone, which was discovered by scientists at the Institute for Cancer Research at London’s Royal Marsden Hospital, costs around £36,000 a year.
Men who take it in pill form four times a day live an average of four months longer.
Owen Sharp, of the Prostate Cancer Charity, said: ‘Four months may not appear to be very long, but those months could mean a man lives to see the birth of a grandchild or even just give him the chance to do more of the things we all take for granted – whilst still enjoying a good quality of life with much less pain and few side-effects.’
Original Article: DailyMail
What do you think about this? Any insight or advice?
Don't be shy!
Best,
Gilda